Healthcare
Gilead Sciences Inc. (GILD)
Gilead Sciences Inc. stock analysis and opportunity scoring
$157.37
As of Oct 15
↑ +2.49%
Gilead Sciences Inc. (GILD) at a glance
Gilead Sciences Inc. (GILD) is a publicly traded company in the Healthcare - Drug Manufacturers - General sector tracked by MKD Intelligence.
GILD last traded at $157.37 up 2.49% on the session as of 2026-10-15.
MKD Intelligence assigns GILD a composite opportunity score of 68 out of 100, indicating favourable conditions across trend, momentum and volume factors.
The risk score for GILD is 34 out of 100 (moderate), where a higher number means greater expected volatility.
Healthcare sector comparison
GILD has a composite opportunity score of 68/100, above the 64.9/100 average across 84 tracked Healthcare stocks. UNH leads the sector at 78/100.
Price History
High
$157.37
Low
$144.23
Period
Oct 15 - Sep 18 (20d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEs - Fierce Biotech
Fierce Biotech · 3d ago
Upcoming Events
Data as of Oct 17
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.